| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
|---|
| 10/19/2004 | US6806229 Herbicidally active pyridine sulfonyl urea derivatives |
| 10/19/2004 | CA2169380C The preparation of pyrazole and its derivatives |
| 10/14/2004 | US20040204423 Crystalline antifungal polymorph |
| 10/14/2004 | US20040204417 For therapy of cancer |
| 10/13/2004 | EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 10/13/2004 | EP1465882A2 Hetrocyclic modulators of nuclear receptors |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1044193B1 Process for preparing triazole antimycotic compounds |
| 10/13/2004 | EP0824317B1 An agricultural and horticultural disease controller and a method for controlling the diseases |
| 10/13/2004 | CN1537101A Pyridine matrix metalloproteinase inhibitors |
| 10/13/2004 | CN1170826C Amide compounds |
| 10/12/2004 | US6803367 Substance for inducing apoptosis |
| 10/12/2004 | US6802882 Fertilization mixture containing pyrazole compound |
| 10/12/2004 | CA2132098C Antimicrobial imidazoles for regulating the greasiness of the skin |
| 10/07/2004 | WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | US20040198795 Substituted imidazoliums and methods of use therefor |
| 10/07/2004 | US20040198790 Triazole compound containing a phosphonate group |
| 10/07/2004 | US20040198758 N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides |
| 10/07/2004 | US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine. |
| 10/07/2004 | US20040194227 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibres |
| 10/07/2004 | CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/06/2004 | CN1535151A Novel anti-infectives |
| 10/05/2004 | US6800636 Farnesyl protein transferase inhibitors |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 10/05/2004 | CA2103837C Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040192922 Novel azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments |
| 09/30/2004 | US20040192753 Methods of use of thrombin receptor antagonists |
| 09/30/2004 | US20040192748 Heterocyclic compounds |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | CA2519440A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/29/2004 | EP1462453A1 Paraphenylenediamin derivatives comprising a substituted pyrrolidinyl group and bearing a cationic radical as well as their use for dyeing keratinic fibres |
| 09/29/2004 | EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461326A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1064267B1 Novel cationic coupling agents, their use for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods |
| 09/29/2004 | EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 09/29/2004 | EP0928289B1 Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 09/28/2004 | US6797823 Quinoline derivatives and quinazoline derivatives |
| 09/23/2004 | WO2004080974A1 A purification method of ionic liquids to obtain their high purity |
| 09/23/2004 | WO2004080973A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
| 09/23/2004 | US20040186129 2-Aroylimidazole compounds for treating cancer |
| 09/23/2004 | CA2517885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/22/2004 | EP1458715A1 Novel compounds |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP0805148B1 Benzamidoxime derivative, process for production thereof, and agrohorticultural bactericide |
| 09/22/2004 | CN1167701C Method for preparing oxazolidone amine |
| 09/22/2004 | CN1167700C Triazole derivative possessing anti-fungus activity |
| 09/22/2004 | CN1167686C Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds |
| 09/22/2004 | CN1167680C Fused-ring compounds and use thereof as drugs |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/16/2004 | WO2003094839A3 Pyrimidinone compounds, compositions and methods |
| 09/16/2004 | US20040181076 Reaction of carbazolone, forrmaldehyde and amine compound in nonaqueous solution and bonding to water, solvent |
| 09/16/2004 | US20040181067 Tri(cyclo) substituted amide compounds |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
| 09/16/2004 | US20040180942 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders |
| 09/16/2004 | US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine |
| 09/15/2004 | EP1456171A1 Substituted cyclohexane derivatives |
| 09/15/2004 | EP1194227B1 Preparation and use of ionic liquids in microwave-assisted chemical transformations |
| 09/15/2004 | EP0775689B9 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529684A Use of composition of ionic nature as substitute reagent, composition constituting fluorination reagent and using method thereof |
| 09/15/2004 | CN1166652C Preparation method of carbonyl aplpha-substitution nitrogenous compound |
| 09/14/2004 | US6790955 Reacting 2-sulfonamido, nitrobenzoic acid compound with in the presence of a halogenating agent, with formation of the carbonyl halide and its rearrangement; ammonolysis at so2cl group reducing at the nitro group; reacting with carbamate |
| 09/14/2004 | CA2280708C Cetp activity inhibitors |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176432 simplified manner using considerably less process steps and with considerably improved yield and diastereoselectivity |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176418 protease activated receptor (PAR) antagonists will be useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders |
| 09/09/2004 | US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase |
| 09/09/2004 | US20040176364 Aryl substituted thiazinidinones and the use thereof |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
| 09/09/2004 | US20040176251 Phenylsulfonyl ureas, process for their preparation and their use as herbicides and plant growth regulators |
| 09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
| 09/08/2004 | EP1453838A2 Production of ionic liquids |
| 09/08/2004 | EP1453815A1 Metabotropic glutamate receptor-5 modulators |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1289972B1 Serine protease inhibitors |
| 09/08/2004 | EP1084114B1 Isothiazole derivatives useful as anticancer agents |
| 09/08/2004 | EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists |
| 09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
| 09/08/2004 | CN1165546C New derivative of erythromycin, its preparation method and medicinal application |
| 09/08/2004 | CN1165527C Substituted aryl sulphonyl (thio) ureas used as herbicides |
| 09/07/2004 | CA2140146C Process for preparing indole derivatives containing a 1,2,4-triazol-1-yl substituent |
| 09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
| 09/02/2004 | US20040171663 Neuropathy, nephropathy, ophthalmopathy, arteriosclerosis; long lasting; single, low level daily dosage |
| 09/02/2004 | US20040171644 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 09/02/2004 | US20040171638 Chemokine receptor binding heterocyclic compounds |
| 09/02/2004 | US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 09/01/2004 | EP1451164A2 Amide derivatives having improved solubility |
| 09/01/2004 | EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |